back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-09-22 16:12 Tx date 2026-09-16 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Daugaard, Mads
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$120,000
+600,000 vol $0.20 each |
1,845,000 | |
| Older filings | ||||||
| Filed 2026-09-20 09:12 Tx date 2026-03-15 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Seltenrich, Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
| Filed 2026-09-20 09:07 Tx date 2026-09-16 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Seltenrich, Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,000
+300,000 vol $0.20 each |
||
| Filed 2026-09-20 09:06 Tx date 2026-09-16 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Seltenrich, Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,000
+300,000 vol $0.20 each |
||
| Filed 2026-09-20 09:01 Tx date 2026-09-16 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Oishi, Kim David Morris
1 - Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,000
+300,000 vol $0.20 each |
300,000 | |
| Filed 2026-09-20 08:56 Tx date 2026-01-27 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Oishi, Kim David Morris
1 - Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-09-18 12:53 Tx date 2026-03-15 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Seltenrich, Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-09-18 17:05 Tx date 2026-09-16 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Langlands, John Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,000
+75,000 vol $0.20 each |
1,320,000 | |
| Filed 2026-09-18 12:53 Tx date 2026-03-15 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Seltenrich, Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
| Filed 2026-09-18 09:31 Tx date 2026-09-15 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,000
+300,000 vol $0.20 each |
375,000 | |
| Filed 2026-09-04 12:02 Tx date 2026-09-01 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Meshcherekov, Yevgeniy
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$2,000
+10,000 vol $0.20 each |
10,000 | |
| Filed 2026-09-04 11:58 Tx date 2025-04-29 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Meshcherekov, Yevgeniy
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-09-04 11:55 Tx date 2026-09-01 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Meshcherekov, Yevgeniy
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$2,000
+20,000 vol $0.10 each |
35,200 | |
| Filed 2026-09-02 20:34 Tx date 2026-08-31 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Oishi, Kim David Morris
1 - Issuer
Holder: First Growth Equity (Control or Direction)
|
Warrants
11 - Acquisition or disposition carried out privately
|
$20,000
+100,000 vol $0.20 each |
1,000,000 | |
| Filed 2026-09-02 20:28 Tx date 2026-08-31 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Oishi, Kim David Morris
1 - Issuer
Holder: First Growth Equity (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$20,000
+200,000 vol $0.10 each |
2,000,000 | |
| Filed 2026-08-31 08:45 Tx date 2026-08-11 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,000
+100,000 vol $0.10 each |
300,000 | |
| Filed 2026-08-13 07:55 Tx date 2026-08-11 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,000
+100,000 vol $0.10 each |
||
| Filed 2026-08-26 16:28 Tx date 2026-08-11 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Oishi, Kim David Morris
1 - Issuer
Holder: First Growth Equity (Control or Direction)
|
Warrants
11 - Acquisition or disposition carried out privately
|
$180,000
+900,000 vol $0.20 each |
900,000 | |
| Filed 2026-08-26 16:20 Tx date 2026-01-27 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Oishi, Kim David Morris
1 - Issuer
Holder: First Growth Equity (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-08-26 16:18 Tx date 2026-08-11 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Oishi, Kim David Morris
1 - Issuer
Holder: First Growth Equity (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$180,000
+1,800,000 vol $0.10 each |
1,800,000 | |